Mechanisms and Therapies in Cardiovascular Disease
心血管疾病的机制和治疗
基本信息
- 批准号:nhmrc : GNT1052616
- 负责人:
- 金额:$ 836.07万
- 依托单位:
- 依托单位国家:澳大利亚
- 项目类别:Programs
- 财政年份:2014
- 资助国家:澳大利亚
- 起止时间:2014-01-01 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Cardiovascular disease (CVD) claims 1 person every 10 min in Australia and causes 1 in 3 deaths worldwide. The molecular and cellular processes underlying atherosclerosis, vascular injury and thrombosis are highly complex and not well understood. A multifaceted approach is needed to effectively address these key challenges. This Program brings together world experts in these areas to interrogate gaps in our basic understanding of CVD, and to develop novel therapies for CVD patients by exploiting new knowledge through integrated research.
在澳大利亚,每10分钟就有1人死于心血管疾病(CVD),全世界每3人死亡中就有1人死于心血管疾病。动脉粥样硬化、血管损伤和血栓形成的分子和细胞过程是高度复杂的,目前还不清楚。要有效应对这些关键挑战,需要采取多方面的办法。该项目汇集了这些领域的世界专家,探讨我们对心血管疾病基本认识的差距,并通过综合研究开发新知识,为心血管疾病患者开发新的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Prof Beng Chong其他文献
Prof Beng Chong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Prof Beng Chong', 18)}}的其他基金
Heparin Induced Thrombocytopenia (HIT): further characterization of disease mechanism will improve patient treatment
肝素诱导血小板减少症(HIT):疾病机制的进一步表征将改善患者治疗
- 批准号:
nhmrc : 1109745 - 财政年份:2016
- 资助金额:
$ 836.07万 - 项目类别:
Project Grants
Novel Mechanisms, Molecular Targets and Therapies in Cardiovascular Disease
心血管疾病的新机制、分子靶点和疗法
- 批准号:
nhmrc : 1052616 - 财政年份:2014
- 资助金额:
$ 836.07万 - 项目类别:
Program Grants
Heparin-induced thrombocytopenia and thrombosis: Better understanding of pathogenesis and improving diagnosis and treatment
肝素诱导的血小板减少症和血栓形成:更好地了解发病机制并改进诊断和治疗
- 批准号:
nhmrc : 1028803 - 财政年份:2012
- 资助金额:
$ 836.07万 - 项目类别:
Project Grants
Drug-induced immune thrombocytopenia: Understanding the disease mechanisms is the key to better treatment
药物引起的免疫性血小板减少症:了解疾病机制是更好治疗的关键
- 批准号:
nhmrc : 1012409 - 财政年份:2011
- 资助金额:
$ 836.07万 - 项目类别:
NHMRC Project Grants
Regulation of mammalian heart development by transcription factors FHL2, GATA-4 & FOG-2
转录因子 FHL2、GATA-4 对哺乳动物心脏发育的调节
- 批准号:
DP0558687 - 财政年份:2005
- 资助金额:
$ 836.07万 - 项目类别:
Discovery Projects
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Decision Support for Older and Frail Patients Considering Advanced Cardiovascular Therapies: Improving Models of Personal Values Clarification
考虑先进心血管治疗的老年和体弱患者的决策支持:改进个人价值观澄清模型
- 批准号:
10471806 - 财政年份:2020
- 资助金额:
$ 836.07万 - 项目类别:
Decision Support for Older and Frail Patients Considering Advanced Cardiovascular Therapies: Improving Models of Personal Values Clarification
考虑先进心血管治疗的老年和体弱患者的决策支持:改进个人价值观澄清模型
- 批准号:
10222782 - 财政年份:2020
- 资助金额:
$ 836.07万 - 项目类别:
Decision Support for Older and Frail Patients Considering Advanced Cardiovascular Therapies: Improving Models of Personal Values Clarification
考虑先进心血管治疗的老年和体弱患者的决策支持:改进个人价值观澄清模型
- 批准号:
10685586 - 财政年份:2020
- 资助金额:
$ 836.07万 - 项目类别:
Decision Support for Older and Frail Patients Considering Advanced Cardiovascular Therapies: Improving Models of Personal Values Clarification
考虑先进心血管治疗的老年和体弱患者的决策支持:改进个人价值观澄清模型
- 批准号:
10040875 - 财政年份:2020
- 资助金额:
$ 836.07万 - 项目类别:
Miniaturisation and design-for-manufacture of a fibre-optic pressure and flow sensor for guiding minimally invasive cardiovascular therapies
用于指导微创心血管治疗的光纤压力和流量传感器的小型化和制造设计
- 批准号:
42920 - 财政年份:2020
- 资助金额:
$ 836.07万 - 项目类别:
Study
Development of novel therapies for cardiovascular diseases by targeting immunosenescence
通过靶向免疫衰老开发心血管疾病新疗法
- 批准号:
18K15197 - 财政年份:2018
- 资助金额:
$ 836.07万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Use of Registries, Claims and Health System Data to Enhance the Evaluation of Cardiovascular Therapies in Clinical Trials
使用注册、索赔和卫生系统数据来加强临床试验中心血管治疗的评估
- 批准号:
9897550 - 财政年份:2017
- 资助金额:
$ 836.07万 - 项目类别:
Development of exercise and diet therapies for the improvement of risk of cardiovascular disease targeting novel myokine
针对新型肌因子开发运动和饮食疗法以改善心血管疾病的风险
- 批准号:
17H02182 - 财政年份:2017
- 资助金额:
$ 836.07万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Novel Mechanisms, Molecular Targets and Therapies in Cardiovascular Disease
心血管疾病的新机制、分子靶点和疗法
- 批准号:
nhmrc : 1052616 - 财政年份:2014
- 资助金额:
$ 836.07万 - 项目类别:
Program Grants
Cardiovascular Safety of Combination Therapies for Type 2 Diabetes Mellitus
2 型糖尿病联合疗法的心血管安全性
- 批准号:
9107897 - 财政年份:2013
- 资助金额:
$ 836.07万 - 项目类别:














{{item.name}}会员




